Ramsay Health Care Ltd (ASX: RHC) shares raced 10.1% higher to $42.02 during Thursday afternoon trade.
Investors appear to be rewarding the healthcare company for its return to profitability, revenue growth, and improved operational performance. Ramsay Health Care published financial results for the first half of fiscal year 2026 on Thursday morning.
Over the past 12 months, Ramsay Health Care shares have risen 24%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has jumped 11% over the same period.
Image source: Getty Images
Robust financial results
Ramsey Health Care unveiled robust financial first-half FY26 results. It reported marked improvements across key performance metrics, which have been well received by investors.
The company's half-year results to 31 December 2025 show substantial progress after a challenging prior period. Ramsay delivered solid revenue growth, with group income rising nearly 9.7% to approximately $9.34 billion. This was down to patient activity picking up and case acuity increasing across its network.
Back in black
Net profit after tax attributable to owners swung back into positive territory at $160.7 million, compared with a loss in the same period last year. Underlying EBIT grew 7.3% to around $536.7 million.
Earnings per share improved sharply, and the board declared a fully franked interim dividend of 42.5 cents per share, up 6.3% year-on-year. Ramsay Health Care has suspended its Dividend Reinvestment Plan for this dividend.
Australian network stands out
The company's Australian hospital network led the charge, delivering stronger margins and solid admissions growth. Meanwhile, its UK acute hospitals and European operations continue to battle funding constraints and tariff pressure.
Management also pushed ahead with its portfolio reshuffle, confirming plans for a proposed in-specie distribution of its European arm, Ramsay Santé, to shareholders. This move is designed to unlock value and tighten the company's focus on its core markets.
What next for Ramsay Health Care shares?
The company has returned to profitability and is expanding margins. That's a clear sign its operations are regaining momentum. Strong cash flow and dividend growth also point to tighter financial discipline. And with a diversified global footprint and meaningful scale across Australia and Europe, Ramsay isn't relying on just one market to drive earnings.
Looking ahead, the board of Ramsay Health Care shares expects EBIT in Australia to keep climbing, driven by solid activity growth, revenue indexation, and tighter cost control. Group-wide, management is sharpening its focus on capital discipline and productivity gains. In a clear signal of that shift, Ramsay has trimmed FY26 capex guidance to $755–795 million.
That said, risks haven't disappeared. Ongoing public healthcare funding constraints in Europe and the UK could continue to squeeze margins. On top of that, the proposed demerger of Ramsay Santé adds strategic complexity and potential transition risk.
